Article
Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Mar 2009
Chomel Clémence, Cazes Aurélie, Faye Clément, Bignon Marine, Gomez Elisa, Ardidie-Robouant Corinne, Barret Alain, Ricard-Blum Sylvie, Muller Laurent, Germain Stéphane, Monnot Catherine
Abstract excerpt
Angiopoietin-like 4 (ANGPTL4) is involved in angiogenesis and lipid metabolism. It is secreted by liver and adipose tissues and cleaved to generate circulating coiled-coil domain (CCD) and fibrinogen-like domain (FLD) fragments. The full-length ANGPTL4 produced by hypoxic endothelial cells interacts with the extracellular matrix (ECM). The ECM-bound and soluble forms of ANGPTL4 have antiangiogenic properties. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
